Ontology highlight
ABSTRACT:
SUBMITTER: Ziegler YS
PROVIDER: S-EPMC6145347 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
Ziegler Yvonne S YS Moresco James J JJ Tu Patricia G PG Yates John R JR Nardulli Ann M AM
Clinical proteomics 20180919
In recent years, there has been an emphasis on personalizing breast cancer treatment in order to avoid the debilitating side effects caused by broad-spectrum chemotherapeutic drug treatment. Development of personalized medicine requires the identification of proteins that are expressed by individual tumors. Herein, we reveal the identity of plasma membrane proteins that are overexpressed in estrogen receptor α-positive, HER2-positive, and triple negative breast cancer cells. The proteins we iden ...[more]